Edition:
United States

Strongbridge Biopharma plc (SBBP.OQ)

SBBP.OQ on NASDAQ Stock Exchange Global Select Market

4.69USD
22 Jan 2019
Change (% chg)

-- (--)
Prev Close
$4.69
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
69,712
52-wk High
$9.25
52-wk Low
$3.82

Chart for

About

Strongbridge Biopharma plc is a global commercial-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies for a range of diseases. The Company's commercial product, KEVEYIS (dichlorphenamide), is indicated for the treatment of hyperkalemic, hypokalemic and related variants of... (more)

Overall

Beta: --
Market Cap(Mil.): $233.09
Shares Outstanding(Mil.): 47.19
Dividend: --
Yield (%): --

Financials

  SBBP.OQ Industry Sector
P/E (TTM): -- 29.45 30.88
EPS (TTM): -1.63 -- --
ROI: -71.12 14.34 13.80
ROE: -- 15.85 15.29

Earnings vs. Estimates